Pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management starts here. We're hiring for our clinical and computational sciences team. Learn more and apply: https://hrbn.gr/3MFhwaz
Harbinger Health’s Post
More Relevant Posts
-
I am thrilled that we get to announce this partnership today between Flatiron Health and Caris Life Sciences launching a best-in-class WES/WTS mulyimodal Clinical-omics Database to the market. This type of DNA and RNAseq data coupled with robust clinical data and outcomes will allow oncology drug developers to find new targets, understand drug resistance and super responders, and develop more accurate biomarkers. It's also the perfect type of "golden data" to power AI drug discovery. When working at the Broad in drug discovery, I remember one of the biggest questions was about the relevance of the in vitro targets we discovered and if our disease models were reflecting real world biology. Now, with this type of data we can better understand cancer biology in the real world. I can't wait to see all the amazing science that will come from this partnership! #clinicogenomics #genomics #cancerresearch #realworlddata #drugdiscovery
ANNOUNCED TODAY: Caris Life Sciences and Flatiron Health are partnering to offer a new multimodal data offering that combines Caris’s large-scale, clinico-genomic database and Flatiron’s longitudinal clinical data. The datasets will include Whole Exome and Whole Transcriptome sequencing coverage alongside real-world patient outcomes, expanding our ability to support the preclinical stages of drug discovery, powering novel research to improve and extend the lives of people with cancer. Learn more: https://lnkd.in/e-kz6_3Y
-
🚀 Exciting News in Oncology Research! 🌟 The depth of Flatiron Health clinical data, curated with over a decade of Oncology RWE expertise, coupled with Caris Life Sciences Whole Exome and Whole Transcriptome sequencing coverage is an unmatched offering. Our life sciences partners are buzzing with excitement, and I can't help but share a direct quote that perfectly captures the spirit of innovation: "The depth of real world clinical data matched with WES & WTS will unlock research questions that previously weren't on the table." 🚀🤔💡 Thrilled to be at the forefront of groundbreaking research, we're turning possibilities into realities. #rwe #oncology #clinicalresearch
ANNOUNCED TODAY: Caris Life Sciences and Flatiron Health are partnering to offer a new multimodal data offering that combines Caris’s large-scale, clinico-genomic database and Flatiron’s longitudinal clinical data. The datasets will include Whole Exome and Whole Transcriptome sequencing coverage alongside real-world patient outcomes, expanding our ability to support the preclinical stages of drug discovery, powering novel research to improve and extend the lives of people with cancer. Learn more: https://lnkd.in/e-kz6_3Y
-
AI Consultant @ Joseph Pareti's AI Consulting Services | AI in CAE, HPC, Health Science
Explanations and Discussion about insitro 's AI Applications for Oncology. Here are some observations from a ground-breaking study on Insitro's creative application of AI in oncology. This work demonstrates how #artificialintelligence platforms— #embeddings , DNA-encoded libraries, or #DELs —and machine learning models are revolutionizing drug development and patient risk assessment in the context of cancer treatment. These technologies open up new possibilities for forecasting tumor behavior and finding treatment targets by combining genetic and histological data, opening the door to precision medicine in the field of oncology. This is a promising time for AI to advance patient outcomes and deepen our understanding of #cancer . Finally, I obtained further insights from the Insitro slides through #gpt4 and the conversation is reported here: https://lnkd.in/dEHqZj-k #DrugDiscovery #Oncology #PrecisionMedicine #AIInHealthcare #machinelearning
-
New Blog Post from TD2! Explore how Aura Imaging Software 4.0 enhances preclinical oncology research. Our latest post explains how this advanced software improves imaging precision and clarity, providing detailed insights into tumor biology and treatment responses. Learn about the key features of Aura 4.0, including Smart Exposure, high-quality luminescence and fluorescence imaging, advanced data analysis tools, and seamless integration with the Spectral Instruments Imaging AMI HTX. See how TD2's cutting-edge technologies and expertise are advancing cancer research. Read more: https://hubs.li/Q02KBv_b0 #OncologyResearch #PreclinicalStudies #CancerResearch #ImagingSoftware #TD2
-
-
Planning on conducting #OrthotopicTumorModels? #InVivoImaging will be critical! Happy to discuss how Translational Drug Development (TD2)'s expertise and experience can help efficiently advance your therapeutic from #BenchToBedside DM or email (mkoratich@td2inc.com) & #HaveAGreatDay #HAGD !!!
New Blog Post from TD2! Explore how Aura Imaging Software 4.0 enhances preclinical oncology research. Our latest post explains how this advanced software improves imaging precision and clarity, providing detailed insights into tumor biology and treatment responses. Learn about the key features of Aura 4.0, including Smart Exposure, high-quality luminescence and fluorescence imaging, advanced data analysis tools, and seamless integration with the Spectral Instruments Imaging AMI HTX. See how TD2's cutting-edge technologies and expertise are advancing cancer research. Read more: https://hubs.li/Q02KBv_b0 #OncologyResearch #PreclinicalStudies #CancerResearch #ImagingSoftware #TD2
-
-
The countdown to #AACR2024 is on! As leaders in drug discovery and development, we're gearing up to exchange ideas, collaborate, and accelerate progress in cancer research. Check out our full scientific program and book a meeting with our experts here - https://hubs.ly/Q02pLrpT0 #researchneverstops
AACR 2024 | Evotec Posters
-
The future of oncology is data-driven, but not just any data—genetically diverse data. PAICON is breaking barriers in cancer diagnostics by maximizing the power of AI and big data. Want to know how? Check this out #AI4Oncology #HealthTech #CancerResearch #AIHealth #DigitalHealthcare
-
-
Watch this webinar to gain insights into the implementation of cancer genomics (CGx) testing using NGS. #thermofisheremp
On-demand webinar: NGS for hereditary cancer testing
thermofisher.com
-
Gain insight into cutting-edge techniques reshaping cancer research. Watch our webinar featuring breakthroughs in 3D cell culture and protein characterization. Delve into how these advancements are reshaping cancer exploration and driving scientific discovery. Don't miss out! Secure your spot now! #alwayscurious
Revolutionizing Cancer Modeling with 3D Cell Culture and Protein Characterization
event.on24.com
-
Gain insight into cutting-edge techniques reshaping cancer research. Watch our webinar featuring breakthroughs in 3D cell culture and protein characterization. Delve into how these advancements are reshaping cancer exploration and driving scientific discovery. Don't miss out! Secure your spot now! #alwayscurious
Revolutionizing Cancer Modeling with 3D Cell Culture and Protein Characterization
event.on24.com
